Charles River Laboratories Announces Second-Quarter 2021 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/24/2026
- S&P 500, Nasdaq end down on tech stocks, investors weigh Iran moves
- Oil drops more than $2 despite new US sanctions on Iran
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- Wattmore and Eos Energy strike non-exclusive storage software deal
- Grand Canyon Education places CFO on leave amid stock trade probe
- S&P 500, Nasdaq end down on tech stocks, investors weigh Iran moves
- Funds sell $44bn in semiconductors on AI concerns
- RUM Group signs $13.7 billion GPU services deal, issues warrants
Charles River Laboratories (CRL) Tops Q2 EPS by 23c; Raises Guidance
August 4, 2021 7:08 AM EDTCharles River Laboratories (NYSE: CRL) reported Q2 EPS of $2.61, $0.23 better than the analyst estimate of $2.38. Revenue for the quarter came in at $914.6 million versus the consensus estimate of $880.65 million.
James C. Foster, Chairman, President and Chief Executive Officer, said, The strength of our leading, non-clinical... More
